Mini Review
Published on 03 May 2018
Targeting VEGF/VEGFR to Modulate Antitumor Immunity
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2018.00978
- 47,312 views
- 582 citations
15 articles related to "Vegfvegfr"
Articles
Systematic Review
Published on 11 Jun 2024
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1419256
- 5,013 views
- 6 citations
Review
Published on 04 Jan 2024
Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1307860
- 23,193 views
- 109 citations
Review
Published on 17 Jul 2020
Neuropilins, as Relevant Oncology Target: Their Role in the Tumoral Microenvironment
in Molecular and Cellular Oncology
Frontiers in Cell and Developmental Biology
doi 10.3389/fcell.2020.00662
- 12,757 views
- 47 citations
Original Research
Published on 29 Sep 2021
A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2021.734544
- 4,881 views
- 6 citations
Review
Published on 01 Oct 2013
Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2013.00259
- 10,693 views
- 70 citations
Case Report
Published on 23 Nov 2020
Case Report: Gastrointestinal PEComa With TFE3 Rearrangement Treated With Anti-VEGFR TKI Apatinib
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.582087
- 4,097 views
- 28 citations
Review
Published on 02 Jun 2021
The Combination of Immune Checkpoint Blockade and Angiogenesis Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.689132
- 14,680 views
- 97 citations
Original Research
Published on 29 Mar 2019
Rational Design of Antiangiogenic Helical Oligopeptides Targeting the Vascular Endothelial Growth Factor Receptors
in Chemical Biology
Frontiers in Chemistry
doi 10.3389/fchem.2019.00170
- 5,739 views
- 13 citations
Original Research
Published on 02 Dec 2021
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.778978
- 39,065 views
- 48 citations
Original Research
Published on 09 May 2025
Unveiling the molecular mechanisms of stigmasterol on diabetic retinopathy: BNM framework construction and experimental validation
in Ophthalmology
Frontiers in Medicine
doi 10.3389/fmed.2025.1537139
- 3,200 views
- 1 citation
Original Research
Published on 22 Oct 2024
Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1488853
- 5,694 views
- 11 citations
Mini Review
Published on 19 Aug 2022
IL-8 and its role as a potential biomarker of resistance to anti-angiogenic agents and immune checkpoint inhibitors in metastatic renal cell carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.990568
- 7,627 views
- 26 citations
Case Report
Accepted on 19 Feb 2026
A case report of rare cardiac angiosarcoma and experience of immunotherapy/ targeted therapy
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
Original Research
Published on 20 Jun 2022
Anti-Angiogenetic and Anti-Lymphangiogenic Effects of a Novel 2-Aminobenzimidazole Derivative, MFB
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.862326
- 4,949 views
- 9 citations